about
Cholesterol in the Pathogenesis of Alzheimer's, Parkinson's Diseases and Autism: Link to Synaptic DysfunctionDistinct α2 Na,K-ATPase membrane pools are differently involved in early skeletal muscle remodeling during disuse.Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.24S-Hydroxycholesterol enhances synaptic vesicle cycling in the mouse neuromuscular junction: Implication of glutamate NMDA receptors and nitric oxide.Similar oxysterols may lead to opposite effects on synaptic transmission: Olesoxime versus 5α-cholestan-3-one at the frog neuromuscular junction.The involvement of P2Y12 receptors, NADPH oxidase, and lipid rafts in the action of extracellular ATP on synaptic transmission at the frog neuromuscular junction.The Effects of β (2) -Adrenoreceptor Activation on the Contractility, Ca-Signals and Nitric Oxide Production in the Mouse Atria.The role of cholesterol in the exo- and endocytosis of synaptic vesicles in frog motor nerve endings.The role of cGMP-dependent signaling pathway in synaptic vesicle cycle at the frog motor nerve terminals.β2-adrenoceptor agonist-evoked reactive oxygen species generation in mouse atria: implication in delayed inotropic effect.Role of membrane cholesterol in spontaneous exocytosis at frog neuromuscular synapses: reactive oxygen species-calcium interplay.Clomipramine counteracts lipid raft disturbance due to short-term muscle disuse.Oxysterol, 5α-cholestan-3-one, modulates a contractile response to β2-adrenoceptor stimulation in the mouse atria: Involvement of NO signaling.Effects of 5α-cholestan-3-one on the synaptic vesicle cycle at the mouse neuromuscular junction.Membrane lipid rafts are disturbed in the response of rat skeletal muscle to short-term disuse.Inhibition of protein kinase C affects on mode of synaptic vesicle exocytosis due to cholesterol depletion.Cholesterol regulates contractility and inotropic response to β2-adrenoceptor agonist in the mouse atria: Involvement of Gi-protein-Akt-NO-pathway.Mechanisms that minimize retinal impact of apolipoprotein E absenceCholesterol and the Safety Factor for Neuromuscular TransmissionThe vesicle cycle in motor nerve endings of the mouse diaphragmIncreased non-quantal release of acetylcholine after inhibition of endocytosis by methyl-β-cyclodextrin: the role of vesicular acetylcholine transporterThe role of membrane cholesterol in neurotransmitter release from motor nerve terminalsMechanisms of delayed inotropic response of mouse atria to activation of β(2)-adrenoreceptorsRole of cholesterol in the maintenance of endplate electrogenesis in rat diaphragmThe role of membrane cholesterol in effects of β2 adrenoreceptors activation of the mouse atrium24S-hydroxycholesterol suppresses neuromuscular transmission in SOD1(G93A) mice: A possible role of NO and lipid raftsBreakdown of phospholipids and the elevated nitric oxide are involved in M3 muscarinic regulation of acetylcholine secretion in the frog motor synapseCholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain DiseasesChanges in Membrane Ceramide Pools in Rat Soleus Muscle in Response to Short-Term DisuseAction of Hydrogen Peroxide on Synaptic Transmission at the Mouse Neuromuscular JunctionBrain cholesterol metabolite 24-hydroxycholesterol modulates inotropic responses to β-adrenoceptor stimulation: The role of NO and phosphodiesteraseExtracellular ATP and β-NAD alter electrical properties and cholinergic effects in the rat heart in age-specific mannerCYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD MiceThe key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatmentThe Interplay between Retinal Pathways of Cholesterol Output and Its Effects on Mouse RetinaMembrane cholesterol oxidation downregulates atrial β-adrenergic responses in ROS-dependent mannerOxysterol modulates neurotransmission via liver-X receptor/NO synthase-dependent pathway at the mouse neuromuscular junctionsOlesoxime, a cholesterol-like neuroprotectant restrains synaptic vesicle exocytosis in the mice motor nerve terminals: Possible role of VDACsStudies of ApoD-/- and ApoD-/-ApoE-/- mice uncover the APOD significance for retinal metabolism, function, and status of chorioretinal blood vessels
P50
Q33607803-C3C0F8AB-E506-411D-B04E-70D409AD044EQ36505279-261E14CE-30E9-44DF-9AB2-1C3B319EE4FEQ38813613-44860E98-F1AA-4BE0-BDC9-478B3C406121Q38983415-620352E9-A737-4EE6-8B05-85DBAAE6E275Q39832269-07F5F375-050B-4DC8-BB9C-22C6183B6B21Q41739053-665AB8E8-C653-4A66-A02D-0C6BBB055803Q42153122-138D53BF-B696-4F39-BB7F-C3F156ED4F9DQ42948673-02081AE1-6925-4548-83C8-8F0796646DCBQ46217430-3D5E20F7-EC0B-44D0-88BB-22A384721DC8Q46680842-75FABDF6-6629-4168-BF62-884A3DD60F05Q46824077-224506C6-5201-4E59-8813-63CD495A2AAAQ47616143-5D2BBB14-2F11-4195-810F-2584948D966AQ47828022-8DCC0F84-7C31-40AA-A5F9-BB304FC5061DQ48105921-A4BB9155-AC98-4983-9D3E-19036D9C2F38Q52894005-5BF20A81-8AED-4FB7-8D23-B9BC74C12864Q54306423-82ABFD4F-A2F8-4D5D-8DF3-CF9C0A830E16Q55022829-E061512F-D799-424F-A30F-816448EBBAD4Q58545609-856431BA-A582-496C-813C-D2D78CBEADFEQ64088611-B1E4A994-1480-4203-A7CD-EC7B79B98DDBQ83389148-CB369DE6-992B-4BB7-905A-4826658A8993Q84072303-DB5967D9-B5CE-46FC-B1D0-D7D9CD637C91Q84504806-A5AAB9D8-A78C-4F5D-AC23-866E5132E6FEQ85368639-E316A3C4-DFCD-4D1C-B19C-C4B040863799Q86499662-6D6AD327-3FA5-47AB-B175-796EFC5D1155Q87498780-4E118A44-CFFC-4A79-899E-4C4BF9C0A8E3Q88088058-325BF74D-965C-49F7-A95B-8616C171251AQ89580710-B2537C91-278C-460C-94CC-B564D0403546Q90005109-DAE1043E-82EA-4D9B-817D-FD3AF6636DFCQ90418914-84A84E01-7D8B-4D5D-840B-2A6DCB8CD2C4Q90799830-70AF9B52-02BD-42FF-936F-5F105EF52AAFQ91314484-4EC870CF-61C3-4547-9863-D1B3828DDC8DQ91524241-082C5C94-0697-44C2-B33E-8D18FB06EA63Q91811966-F3626B07-B39E-4893-A65D-CE5B0114F2EDQ91823541-68B14C9B-E7B9-4028-A80F-69667C7DD2BFQ92012532-004F630C-7BCE-41E0-8CC6-19DD3F765AA6Q92130506-12E36828-4EC3-4C2B-A6A3-FBFA77FBC325Q92535453-7BDF7184-A638-4F4A-B987-D0586FD0B168Q95311254-E0ED95D6-DC81-49CD-93BA-3FC81FBE4630Q95643655-75FC9C90-EE81-49CF-B146-C76D229F2E72
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alexey M Petrov
@nl
Alexey M Petrov
@sl
Alexey M. Petrov
@en
Alexey M. Petrov
@es
type
label
Alexey M Petrov
@nl
Alexey M Petrov
@sl
Alexey M. Petrov
@en
Alexey M. Petrov
@es
prefLabel
Alexey M Petrov
@nl
Alexey M Petrov
@sl
Alexey M. Petrov
@en
Alexey M. Petrov
@es
P106
P1153
16234407000
56428434100
P31
P496
0000-0002-1432-3455